ConductScience.org, home

Paper39488602

Analysis of molecular mechanisms of delafloxacin resistance in Escherichia coli.

Kubicskó A and 3 others. Sci Rep, 2024. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Analysis of molecular mechanisms of delafloxacin resistance in Escherichia coli. Papers, record 39488602. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39488602

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Analysis of molecular mechanisms of delafloxacin resistance in Escherichia coli.
PubMed
Journal
Sci Rep
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
2.46, provisional
iCite
Revised in PubMed
2024-11-05
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kubicskó AAndrás
2Kamotsay KKatalin
3Szabó DDóra
4Kocsis BBéla

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Escherichia coliMajor topic
FluoroquinolonesMajor topic
Microbial Sensitivity TestsMajor topic
Anti-Bacterial AgentsMajor topic
Drug Resistance, BacterialMajor topic
Mutation
Whole Genome Sequencing
Humans
DNA Gyrase
DNA Topoisomerase IV
Escherichia coli Infections
beta-Lactamases

Source PubMed

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No "0272".HUN-REN-SU Human Microbiota Research GroupPubMed
952491-AmReSuEuropean Union's Horizon 2020 research and innovation programPubMed
952491-AmReSuEuropean Union's Horizon 2020 research and innovation programPubMed
János Bolyai Research Scholarship (BO/00286/22/5)Hungarian Academy of SciencesPubMed

Source PubMed

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127,215,369Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin.Ann Clin Microbiol Antimicrob2016https://conductscience.org/library/papers/27215369PubMed
236,459,132Distribution of virulence determinants among Escherichia coli ST131 and its H30/H30-Rx subclones in Turkey.Acta Microbiol Immunol Hung2023https://conductscience.org/library/papers/36459132PubMed
332,152,527Antibiotics in the clinical pipeline in October 2019.J Antibiot (Tokyo)2020https://conductscience.org/library/papers/32152527PubMed
438,667,039Genomic Epidemiology of C2/H30Rx and C1-M27 Subclades of Escherichia coli ST131 Isolates from Clinical Blood Samples in Hungary.Antibiotics (Basel)2024https://conductscience.org/library/papers/38667039PubMed
512,812,718Detection of mutations in quinolone resistance-determining regions in levofloxacin- and methicillin-resistant Staphylococcus aureus: effects of the mutations on fluoroquinolone MICs.Diagn Microbiol Infect Dis2003https://conductscience.org/library/papers/12812718PubMed
637,887,221Emergence and Genomic Features of a mcr-1 Escherichia coli from Duck in Hungary.Antibiotics (Basel)2023https://conductscience.org/library/papers/37887221PubMed
738,622,998High-risk Escherichia coli clones that cause neonatal meningitis and association with recrudescent infection.Elife2024https://conductscience.org/library/papers/38622998PubMed
836,556,442Emergence and Dissemination of Extraintestinal Pathogenic High-Risk International Clones of Escherichia coli.Life (Basel)2022https://conductscience.org/library/papers/36556442PubMed
938,318,209Whole-Genome Sequencing of an Escherichia coli ST69 Strain Harboring blaCTX-M-27 on a Hybrid Plasmid.Infect Drug Resist2024https://conductscience.org/library/papers/38318209PubMed
1029,250,038Double-Serine Fluoroquinolone Resistance Mutations Advance Major International Clones and Lineages of Various Multi-Drug Resistant Bacteria.Front Microbiol2017https://conductscience.org/library/papers/29250038PubMed
1135,710,924The impact of the ST131 clone on recurrent ESBL-producing E. coli urinary tract infection: a prospective comparative study.Sci Rep2022https://conductscience.org/library/papers/35710924PubMed
1237,375,104Investigation of Delafloxacin Resistance in Multidrug-Resistant Escherichia coli Strains and the Detection of E. coli ST43 International High-Risk Clone.Microorganisms2023https://conductscience.org/library/papers/37375104PubMed
1339,126,340In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates.J Antimicrob Chemother2024https://conductscience.org/library/papers/39126340PubMed
1431,916,915Characterization of O25b-ST131 Escherichia coli Clone Producing CTX-M-15, DHA-4, and CMY-42 in Urinary Tract Infections in a Tunisian Island.Microb Drug Resist2020https://conductscience.org/library/papers/31916915PubMed
1535,095,799Comparison of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates From Rooks (Corvus frugilegus) and Contemporary Human-Derived Strains: A One Health Perspective.Front Microbiol2021https://conductscience.org/library/papers/35095799PubMed
1628,167,542In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014.Antimicrob Agents Chemother2017https://conductscience.org/library/papers/28167542PubMed
1723,827,749Characterization of extended-spectrum β-lactamase (ESBL) producing Escherichia coli strains isolated from animal and human clinical samples in Hungary in 2006-2007.Acta Microbiol Immunol Hung2013https://conductscience.org/library/papers/23827749PubMed
1834,097,486Identification of qnrE3 and qnrE4, New Transferable Quinolone Resistance qnrE Family Genes Originating from Enterobacter mori and Enterobacter asburiae, Respectively.Antimicrob Agents Chemother2021https://conductscience.org/library/papers/34097486PubMed
1938,319,508Reduced susceptibility to aztreonam-avibactam conferred by acquired AmpC-type β-lactamases in PBP3-modified Escherichia coli.Eur J Clin Microbiol Infect Dis2024https://conductscience.org/library/papers/38319508PubMed
2036,363,736Dissemination of High-Risk Clones Enterobacterales among Bulgarian Fecal Carriage Isolates.Microorganisms2022https://conductscience.org/library/papers/36363736PubMed

See all 60 references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42,864,405Efflux modulation as an antimicrobial strategy: mechanisms and translational perspectives.NPJ Drug Discov2026https://conductscience.org/library/papers/42864405PubMed
42,635,419In vitro activity of delafloxacin against enterococcal isolates from male urinary tract infections and genetic determinants of resistance.Microbiol Spectr2026https://conductscience.org/library/papers/42635419PubMed
41,811,471Delafloxacin: what does a new fluoroquinolone offer?Rev Esp Quimioter2026https://conductscience.org/library/papers/41811471PubMed
41,608,681Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens.Front Microbiol2025https://conductscience.org/library/papers/41608681PubMed
41,070,133Analysis of the microbial spectrum of urinary tract infections and antibiotic resistance of UPEC in Central Inner Mongolia, China.Front Microbiol2025https://conductscience.org/library/papers/41070133PubMed
40,836,876Molecular characterization of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae susceptible to delafloxacin.J Antimicrob Chemother2025https://conductscience.org/library/papers/40836876PubMed
40,558,132Variable In Vitro Efficacy of Delafloxacin on Multidrug-Resistant Pseudomonas aeruginosa and the Detection of Delafloxacin Resistance Determinants.Antibiotics (Basel)2025https://conductscience.org/library/papers/40558132PubMed
39,858,348Detection of Delafloxacin Resistance Mechanisms in Multidrug-Resistant Klebsiella pneumoniae.Antibiotics (Basel)2025https://conductscience.org/library/papers/39858348PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39488602

GET https://conductscience.org/api/papers/v1/39488602/references?page=2